Detalhe da pesquisa
1.
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.
Stat Med
; 36(5): 754-771, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27891651
2.
Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series.
Clin Infect Dis
; 71(8): 2021-2022, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459833
3.
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018.
HIV Med
; 20 Suppl 2: s2-s80, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30869189
4.
Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak.
AIDS Res Hum Retroviruses
; 39(11): 581-586, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071153
5.
Use of ß-D-glucan in diagnosis of suspected Pneumocystis jirovecii pneumonia in adults with HIV infection.
Int J STD AIDS
; 32(11): 1074-1077, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34106017
6.
A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol.
Sci Rep
; 7(1): 9447, 2017 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842581
7.
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.
Front Immunol
; 8: 149, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275375
8.
Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study.
PLoS One
; 12(4): e0175596, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426834
9.
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.
AIDS
; 28(9): 1333-9, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24583670